Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.
Identifieur interne : 000247 ( Main/Exploration ); précédent : 000246; suivant : 000248Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.
Auteurs : Paulina M. Gutkin [États-Unis] ; Nicolas D. Prionas [États-Unis] ; Madeline O. Minneci [États-Unis] ; Elena Allen [États-Unis] ; Katy E. Balazy [États-Unis] ; Elham Rahimy [États-Unis] ; Daniel T. Chang [États-Unis] ; Kathleen C. Horst [États-Unis]Source :
- International journal of radiation oncology, biology, physics [ 1879-355X ] ; 2020.
Descripteurs français
- KwdFr :
- Enseignement spécialisé en médecine (statistiques et données numériques), Humains (MeSH), Infections à coronavirus (épidémiologie), Internat et résidence (statistiques et données numériques), Pandémies (MeSH), Pneumopathie virale (épidémiologie), Radio-oncologie (MeSH), Soins aux patients (statistiques et données numériques), Télémédecine (MeSH).
- MESH :
- statistiques et données numériques : Enseignement spécialisé en médecine, Internat et résidence, Soins aux patients.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Humains, Pandémies, Radio-oncologie, Télémédecine.
English descriptors
- KwdEn :
- COVID-19 (MeSH), Coronavirus Infections (epidemiology), Education, Medical, Graduate (statistics & numerical data), Humans (MeSH), Internship and Residency (statistics & numerical data), Pandemics (MeSH), Patient Care (statistics & numerical data), Pneumonia, Viral (epidemiology), Radiation Oncology (MeSH), Telemedicine (MeSH).
- MESH :
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- statistics & numerical data : Education, Medical, Graduate, Internship and Residency, Patient Care.
- COVID-19, Humans, Pandemics, Radiation Oncology, Telemedicine.
Abstract
PURPOSE
Telemedicine was rapidly and ubiquitously adopted during the COVID-19 pandemic. However, there are growing discussions as to its role postpandemic.
METHODS AND MATERIALS
We surveyed patients, radiation oncology (RO) attendings, and RO residents to assess their experience with telemedicine. Surveys addressed quality of patient care and utility of telemedicine for teaching and learning core competencies. Satisfaction was rated on a 6-point Likert-type scale. The quality of teaching and learning was graded on a 5-point Likert-type scale, with overall scores calculated by the average rating of each core competency required by the Accreditation Council for Graduate Medical Education (range, 1-5).
RESULTS
Responses were collected from 56 patients, 12 RO attendings, and 13 RO residents. Patient feedback was collected at 17 new-patient, 22 on-treatment, and 17 follow-up video visits. Overall, 88% of patients were satisfied with virtual visits. A lower proportion of on-treatment patients rated their virtual visit as "very satisfactory" (68.2% vs 76.5% for new patients and 82.4% for follow-ups). Only 5.9% of the new patients and none of the follow-up patients were dissatisfied, and 27% of on-treatment patients were dissatisfied. The large majority of patients (88%) indicated that they would continue to use virtual visits as long as a physical examination was not needed. Overall scores for medical training were 4.1 out of 5 (range, 2.8-5.0) by RO residents and 3.2 (range, 2.0-4.0) by RO attendings. All residents and 92% of attendings indicated they would use telemedicine again; however, most indicated that telemedicine is best for follow-up visits.
CONCLUSIONS
Telemedicine is a convenient means of delivering care to patients, with some limitations demonstrated for on-treatment patients. The majority of both patients and providers are interested in using telemedicine again, and it will likely continue to supplement patient care.
DOI: 10.1016/j.ijrobp.2020.06.047
PubMed: 32890524
PubMed Central: PMC7462793
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.</title><author><name sortKey="Gutkin, Paulina M" sort="Gutkin, Paulina M" uniqKey="Gutkin P" first="Paulina M" last="Gutkin">Paulina M. Gutkin</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Prionas, Nicolas D" sort="Prionas, Nicolas D" uniqKey="Prionas N" first="Nicolas D" last="Prionas">Nicolas D. Prionas</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, University of San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Minneci, Madeline O" sort="Minneci, Madeline O" uniqKey="Minneci M" first="Madeline O" last="Minneci">Madeline O. Minneci</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Allen, Elena" sort="Allen, Elena" uniqKey="Allen E" first="Elena" last="Allen">Elena Allen</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Balazy, Katy E" sort="Balazy, Katy E" uniqKey="Balazy K" first="Katy E" last="Balazy">Katy E. Balazy</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Rahimy, Elham" sort="Rahimy, Elham" uniqKey="Rahimy E" first="Elham" last="Rahimy">Elham Rahimy</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Chang, Daniel T" sort="Chang, Daniel T" uniqKey="Chang D" first="Daniel T" last="Chang">Daniel T. Chang</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Horst, Kathleen C" sort="Horst, Kathleen C" uniqKey="Horst K" first="Kathleen C" last="Horst">Kathleen C. Horst</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address: kateh@stanford.edu.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32890524</idno><idno type="pmid">32890524</idno><idno type="doi">10.1016/j.ijrobp.2020.06.047</idno><idno type="pmc">PMC7462793</idno><idno type="wicri:Area/Main/Corpus">000348</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000348</idno><idno type="wicri:Area/Main/Curation">000348</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000348</idno><idno type="wicri:Area/Main/Exploration">000348</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.</title><author><name sortKey="Gutkin, Paulina M" sort="Gutkin, Paulina M" uniqKey="Gutkin P" first="Paulina M" last="Gutkin">Paulina M. Gutkin</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Prionas, Nicolas D" sort="Prionas, Nicolas D" uniqKey="Prionas N" first="Nicolas D" last="Prionas">Nicolas D. Prionas</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of San Francisco, San Francisco, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, University of San Francisco, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Minneci, Madeline O" sort="Minneci, Madeline O" uniqKey="Minneci M" first="Madeline O" last="Minneci">Madeline O. Minneci</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Allen, Elena" sort="Allen, Elena" uniqKey="Allen E" first="Elena" last="Allen">Elena Allen</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Balazy, Katy E" sort="Balazy, Katy E" uniqKey="Balazy K" first="Katy E" last="Balazy">Katy E. Balazy</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Rahimy, Elham" sort="Rahimy, Elham" uniqKey="Rahimy E" first="Elham" last="Rahimy">Elham Rahimy</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Chang, Daniel T" sort="Chang, Daniel T" uniqKey="Chang D" first="Daniel T" last="Chang">Daniel T. Chang</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Horst, Kathleen C" sort="Horst, Kathleen C" uniqKey="Horst K" first="Kathleen C" last="Horst">Kathleen C. Horst</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address: kateh@stanford.edu.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Department of Radiation Oncology, Stanford University, Stanford</wicri:cityArea></affiliation></author></analytic><series><title level="j">International journal of radiation oncology, biology, physics</title><idno type="eISSN">1879-355X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Education, Medical, Graduate (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Internship and Residency (statistics & numerical data)</term><term>Pandemics (MeSH)</term><term>Patient Care (statistics & numerical data)</term><term>Pneumonia, Viral (epidemiology)</term><term>Radiation Oncology (MeSH)</term><term>Telemedicine (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Enseignement spécialisé en médecine (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (épidémiologie)</term><term>Internat et résidence (statistiques et données numériques)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (épidémiologie)</term><term>Radio-oncologie (MeSH)</term><term>Soins aux patients (statistiques et données numériques)</term><term>Télémédecine (MeSH)</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Education, Medical, Graduate</term><term>Internship and Residency</term><term>Patient Care</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Enseignement spécialisé en médecine</term><term>Internat et résidence</term><term>Soins aux patients</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Humans</term><term>Pandemics</term><term>Radiation Oncology</term><term>Telemedicine</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Pandémies</term><term>Radio-oncologie</term><term>Télémédecine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b></p><p>Telemedicine was rapidly and ubiquitously adopted during the COVID-19 pandemic. However, there are growing discussions as to its role postpandemic.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS AND MATERIALS</b></p><p>We surveyed patients, radiation oncology (RO) attendings, and RO residents to assess their experience with telemedicine. Surveys addressed quality of patient care and utility of telemedicine for teaching and learning core competencies. Satisfaction was rated on a 6-point Likert-type scale. The quality of teaching and learning was graded on a 5-point Likert-type scale, with overall scores calculated by the average rating of each core competency required by the Accreditation Council for Graduate Medical Education (range, 1-5).</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Responses were collected from 56 patients, 12 RO attendings, and 13 RO residents. Patient feedback was collected at 17 new-patient, 22 on-treatment, and 17 follow-up video visits. Overall, 88% of patients were satisfied with virtual visits. A lower proportion of on-treatment patients rated their virtual visit as "very satisfactory" (68.2% vs 76.5% for new patients and 82.4% for follow-ups). Only 5.9% of the new patients and none of the follow-up patients were dissatisfied, and 27% of on-treatment patients were dissatisfied. The large majority of patients (88%) indicated that they would continue to use virtual visits as long as a physical examination was not needed. Overall scores for medical training were 4.1 out of 5 (range, 2.8-5.0) by RO residents and 3.2 (range, 2.0-4.0) by RO attendings. All residents and 92% of attendings indicated they would use telemedicine again; however, most indicated that telemedicine is best for follow-up visits.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Telemedicine is a convenient means of delivering care to patients, with some limitations demonstrated for on-treatment patients. The majority of both patients and providers are interested in using telemedicine again, and it will likely continue to supplement patient care.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32890524</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-355X</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of radiation oncology, biology, physics</Title><ISOAbbreviation>Int J Radiat Oncol Biol Phys</ISOAbbreviation></Journal><ArticleTitle>Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.</ArticleTitle><Pagination><MedlinePgn>416-420</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0360-3016(20)31334-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2020.06.047</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Telemedicine was rapidly and ubiquitously adopted during the COVID-19 pandemic. However, there are growing discussions as to its role postpandemic.</AbstractText><AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">We surveyed patients, radiation oncology (RO) attendings, and RO residents to assess their experience with telemedicine. Surveys addressed quality of patient care and utility of telemedicine for teaching and learning core competencies. Satisfaction was rated on a 6-point Likert-type scale. The quality of teaching and learning was graded on a 5-point Likert-type scale, with overall scores calculated by the average rating of each core competency required by the Accreditation Council for Graduate Medical Education (range, 1-5).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Responses were collected from 56 patients, 12 RO attendings, and 13 RO residents. Patient feedback was collected at 17 new-patient, 22 on-treatment, and 17 follow-up video visits. Overall, 88% of patients were satisfied with virtual visits. A lower proportion of on-treatment patients rated their virtual visit as "very satisfactory" (68.2% vs 76.5% for new patients and 82.4% for follow-ups). Only 5.9% of the new patients and none of the follow-up patients were dissatisfied, and 27% of on-treatment patients were dissatisfied. The large majority of patients (88%) indicated that they would continue to use virtual visits as long as a physical examination was not needed. Overall scores for medical training were 4.1 out of 5 (range, 2.8-5.0) by RO residents and 3.2 (range, 2.0-4.0) by RO attendings. All residents and 92% of attendings indicated they would use telemedicine again; however, most indicated that telemedicine is best for follow-up visits.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Telemedicine is a convenient means of delivering care to patients, with some limitations demonstrated for on-treatment patients. The majority of both patients and providers are interested in using telemedicine again, and it will likely continue to supplement patient care.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gutkin</LastName><ForeName>Paulina M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prionas</LastName><ForeName>Nicolas D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, University of San Francisco, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minneci</LastName><ForeName>Madeline O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balazy</LastName><ForeName>Katy E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimy</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Daniel T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horst</LastName><ForeName>Kathleen C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address: kateh@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA><NlmUniqueID>7603616</NlmUniqueID><ISSNLinking>0360-3016</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004503" MajorTopicYN="N">Education, Medical, Graduate</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007396" MajorTopicYN="N">Internship and Residency</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005791" MajorTopicYN="N">Patient Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018787" MajorTopicYN="Y">Radiation Oncology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>20</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32890524</ArticleId><ArticleId IdType="pii">S0360-3016(20)31334-1</ArticleId><ArticleId IdType="doi">10.1016/j.ijrobp.2020.06.047</ArticleId><ArticleId IdType="pmc">PMC7462793</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Telemed J E Health. 2006 Apr;12(2):128-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16620167</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2012 Jun;31(6):1237-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22665835</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2014 Feb;33(2):258-64</Citation><ArticleIdList><ArticleId IdType="pubmed">24493769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Gutkin, Paulina M" sort="Gutkin, Paulina M" uniqKey="Gutkin P" first="Paulina M" last="Gutkin">Paulina M. Gutkin</name></region><name sortKey="Allen, Elena" sort="Allen, Elena" uniqKey="Allen E" first="Elena" last="Allen">Elena Allen</name><name sortKey="Balazy, Katy E" sort="Balazy, Katy E" uniqKey="Balazy K" first="Katy E" last="Balazy">Katy E. Balazy</name><name sortKey="Chang, Daniel T" sort="Chang, Daniel T" uniqKey="Chang D" first="Daniel T" last="Chang">Daniel T. Chang</name><name sortKey="Horst, Kathleen C" sort="Horst, Kathleen C" uniqKey="Horst K" first="Kathleen C" last="Horst">Kathleen C. Horst</name><name sortKey="Minneci, Madeline O" sort="Minneci, Madeline O" uniqKey="Minneci M" first="Madeline O" last="Minneci">Madeline O. Minneci</name><name sortKey="Prionas, Nicolas D" sort="Prionas, Nicolas D" uniqKey="Prionas N" first="Nicolas D" last="Prionas">Nicolas D. Prionas</name><name sortKey="Rahimy, Elham" sort="Rahimy, Elham" uniqKey="Rahimy E" first="Elham" last="Rahimy">Elham Rahimy</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000247 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000247 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidStanfordV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32890524
|texte= Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32890524" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidStanfordV1
| This area was generated with Dilib version V0.6.38. |  |